RXDX / Prometheus Biosciences Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5

普羅米修斯生物科學公司
US ˙ NASDAQ ˙ US74349U1088
該符號不再有效

內部人士股份20,539,790 shares
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

N/A

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

N/A

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Prometheus Biosciences Inc內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 RXDX / Prometheus Biosciences Inc 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2021-03-16 Cormorant Asset Management, LLC 375,000 19.0000 375,000 19.0000 7,125,000 359 50.0000 11,625,000 163.16
2021-03-16 Point72 Biotech Private Investments, LLC 800,000 19.0000 800,000 19.0000 15,200,000
2021-03-16 PAPA JOSEPH C 15,000 19.0000 15,000 19.0000 285,000
2021-03-16 Adams Helen C. 500 19.0000 500 19.0000 9,500
2021-03-16 Stenhouse Mark 14,000 19.0000 14,000 19.0000 266,000
2021-03-16 RTW INVESTMENTS, LP 800,000 19.0000 800,000 19.0000 15,200,000
2021-03-16 PERCEPTIVE ADVISORS LLC 850,000 19.0000 850,000 19.0000 16,150,000

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

RXDX / Prometheus Biosciences Inc Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 RXDX / Prometheus Biosciences Inc 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2023-03-08 Cedars Sinai Intellectual Property Co 865,000 114.5900 865,000 114.5900 99,120,350 14 106.4700 -7,023,800 -7.09

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

RXDX / Prometheus Biosciences Inc Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2023-06-16 2023-06-16 4 PAPA JOSEPH C By The Papa Family Charitable Trust RXDX Common Stock D - Sale to Issuer I -10,000 0
2023-06-16 2023-06-16 4 PAPA JOSEPH C RXDX Common Stock D - Sale to Issuer D -7,278 0
2023-06-16 2023-06-16 4 Stenhouse Mark By Stenhouse Family Fund RXDX Common Stock D - Sale to Issuer I -14,000 0
2023-06-16 2023-06-16 4 Stenhouse Mark RXDX Common Stock D - Sale to Issuer D -12,754 0
2023-06-16 2023-06-16 4 McKenna Mark C. RXDX Common Stock D - Sale to Issuer D -178,098 0
2023-06-16 2023-06-16 4 Laur James RXDX Common Stock D - Sale to Issuer D -2,071 0
2023-06-16 2023-06-16 4 Hendrix Martin RXDX Common Stock D - Sale to Issuer D -2,071 0
2023-06-16 2023-06-16 4 Adams Helen C. RXDX Common Stock D - Sale to Issuer D -2,674 0
2023-06-16 2023-06-16 4 Marshall Keith W RXDX Common Stock D - Sale to Issuer D -87,973 0
2023-06-16 2023-06-16 4 Hassan Fred RXDX Common Stock D - Sale to Issuer D -2,123 0
2023-06-16 2023-06-16 4 Swain Judith L RXDX Common Stock D - Sale to Issuer D -2,071 0
2023-06-16 2023-06-16 4 Szela Mary T RXDX Common Stock D - Sale to Issuer D -2,071 0
2023-06-02 2023-06-02 4 McKenna Mark C. RXDX Common Stock M - Exercise D 1.7000 3 0 178,036
2023-06-02 2023-06-02 4 McKenna Mark C. RXDX Common Stock M - Exercise D 2.9000 122,528 355 177,672
2023-06-02 2023-06-02 4 Marshall Keith W RXDX Common Stock M - Exercise D 3.1000 78,162 242 87,973
2023-06-02 2023-06-01 4 Stenhouse Mark By Stenhouse Family Fund RXDX Common Stock J - Other I 14,000 14,000
2023-06-02 2023-06-01 4 Stenhouse Mark RXDX Common Stock J - Other D -14,000 12,708
2023-06-02 2023-06-02 4 PAPA JOSEPH C By The Papa Family Charitable Trust RXDX Common Stock J - Other I 10,000 10,000
2023-06-02 2023-06-02 4 PAPA JOSEPH C RXDX Common Stock J - Other D -10,000 7,278
2023-05-19 2023-05-19 4 Szela Mary T RXDX Common Stock A - Award D 2,071 2,071
2023-05-19 2023-05-19 4 Swain Judith L RXDX Common Stock A - Award D 2,071 2,071
2023-05-19 2023-05-19 4 PAPA JOSEPH C RXDX Common Stock A - Award D 2,278 17,278
2023-05-19 2023-05-19 4 Laur James RXDX Common Stock A - Award D 2,071 2,071
2023-05-19 2023-05-19 4 Hendrix Martin RXDX Common Stock A - Award D 2,071 2,071
2023-05-19 2023-05-19 4 Hassan Fred RXDX Common Stock A - Award D 2,123 2,123
2023-05-19 2023-05-19 4 Adams Helen C. RXDX Common Stock A - Award D 2,174 2,674
2023-04-07 2023-04-05 4 Marshall Keith W RXDX Common Stock S - Sale D 108.4200 -10,000 -1,084 9,811
2023-04-07 2023-04-05 4 Marshall Keith W RXDX Common Stock M - Exercise D 3.7000 10,000 37 19,811
2023-03-17 2023-03-15 4 McKenna Mark C. RXDX Common Stock S - Sale D 116.1400 -25,000 -2,904 55,144
2023-03-17 2023-03-15 4 McKenna Mark C. RXDX Common Stock M - Exercise D 2.9000 25,000 72 80,144
2023-03-08 2023-03-06 4 Marshall Keith W RXDX Common Stock S - Sale D 122.1300 -10,000 -1,221 9,811
2023-03-08 2023-03-06 4 Marshall Keith W RXDX Common Stock M - Exercise D 3.7000 10,000 37 19,811
2023-03-08 2023-03-08 4 Cedars Sinai Intellectual Property Co RXDX Common Stock S - Sale I 114.5900 -865,000 -99,120 4,001,132
2023-03-03 2023-03-03 4 McKenna Mark C. RXDX Common Stock S - Sale D 125.1300 -10,620 -1,329 55,144
2023-03-03 2023-03-03 4 McKenna Mark C. RXDX Common Stock M - Exercise D 3.7000 10,620 39 65,764
2023-03-03 2023-03-01 4 McKenna Mark C. RXDX Common Stock S - Sale D 125.2600 -700 -88 55,144
2023-03-03 2023-03-01 4 McKenna Mark C. RXDX Common Stock M - Exercise D 3.7000 700 3 55,844
2023-02-17 2023-02-15 4 Marshall Keith W RXDX Common Stock S - Sale D 119.3800 -5,000 -597 9,811
2023-02-17 2023-02-15 4 Marshall Keith W RXDX Common Stock M - Exercise D 3.7000 5,000 18 14,811
2023-02-17 2023-02-17 4 McKenna Mark C. RXDX Common Stock S - Sale D 125.1000 -13,680 -1,711 55,144
2023-02-17 2023-02-17 4 McKenna Mark C. RXDX Common Stock M - Exercise D 3.7000 13,680 51 68,824
2023-02-17 2023-02-16 4 McKenna Mark C. RXDX Common Stock S - Sale D 119.8700 -25,000 -2,997 55,144
2023-02-17 2023-02-16 4 McKenna Mark C. RXDX Common Stock M - Exercise D 3.7000 25,000 92 80,144
2023-02-17 2023-02-15 4 McKenna Mark C. RXDX Common Stock S - Sale D 119.4200 -25,000 -2,986 55,144
2023-02-17 2023-02-15 4 McKenna Mark C. RXDX Common Stock M - Exercise D 2.9000 25,000 72 80,144
2023-01-19 2023-01-17 4 Marshall Keith W RXDX Common Stock S - Sale D 119.0000 -5,000 -595 9,811
2023-01-19 2023-01-17 4 Marshall Keith W RXDX Common Stock M - Exercise D 3.7000 5,000 18 14,811
2023-01-19 2023-01-17 4 McKenna Mark C. RXDX Common Stock S - Sale D 118.9900 -25,000 -2,975 55,144
2023-01-19 2023-01-17 4 McKenna Mark C. RXDX Common Stock M - Exercise D 2.9000 25,000 72 80,144
2022-12-13 2022-12-09 4 Stenhouse Mark RXDX Common Stock A - Award D 9,811 26,442
2022-12-13 2022-12-09 4 Marshall Keith W RXDX Common Stock A - Award D 9,811 9,811
2022-12-13 2022-12-09 4 McKenna Mark C. RXDX Common Stock A - Award D 37,113 55,144
2022-05-20 2022-05-19 4 Szela Mary T RXDX Stock Option (Right to Buy) A - Award D 29.02 20,500 20,500
2022-05-20 2022-05-19 4 Swain Judith L RXDX Stock Option (Right to Buy) A - Award D 29.02 20,500 20,500
2022-05-20 2022-05-19 4 PAPA JOSEPH C RXDX Stock Option (Right to Buy) A - Award D 29.02 22,551 22,551
2022-05-20 2022-05-19 4 Laur James RXDX Stock Option (Right to Buy) A - Award D 29.02 20,500 20,500
2022-05-20 2022-05-19 4 Hendrix Martin RXDX Stock Option (Right to Buy) A - Award D 29.02 20,500 20,500
2022-05-20 2022-05-19 4 Hassan Fred RXDX Stock Option (Right to Buy) A - Award D 29.02 21,013 21,013
2022-05-20 2022-05-19 4 Adams Helen C. RXDX Stock Option (Right to Buy) A - Award D 29.02 21,526 21,526
2022-05-20 2022-05-20 4 Stenhouse Mark RXDX Stock Option (Right to Buy) A - Award D 29.56 86,582 86,582
2022-05-20 2022-05-20 4 Marshall Keith W RXDX Stock Option (Right to Buy) A - Award D 29.56 86,582 86,582
2022-05-20 2022-05-20 4 McKenna Mark C. RXDX Stock Option (Right to Buy) A - Award D 29.56 246,639 246,639
2022-04-05 2022-04-05 4 Cedars Sinai Intellectual Property Co RXDX Common Stock J - Other I -142,376 4,866,132
2021-12-03 2021-12-01 4 McKenna Mark C. RXDX Stock Option (Right to Buy) M - Exercise D 2.90 -15,400 122,531
2021-12-03 2021-12-01 4 McKenna Mark C. RXDX Common Stock M - Exercise D 2.9000 15,400 45 15,400
2021-11-16 2021-11-14 4 Andrews Timothy K. RXDX Stock Option (Right to Buy) A - Award D 36.32 54,132 54,132
2021-11-16 2021-11-14 4 Adams Helen C. RXDX Stock Option (Right to Buy) A - Award D 36.32 1,083 1,083
2021-11-16 2021-11-14 4 PAPA JOSEPH C RXDX Stock Option (Right to Buy) A - Award D 36.32 2,165 2,165
2021-11-16 2021-11-14 4 Marshall Keith W RXDX Stock Option (Right to Buy) A - Award D 36.32 102,155 102,155
2021-11-16 2021-11-14 4 Hassan Fred RXDX Stock Option (Right to Buy) A - Award D 36.32 541 541
2021-11-16 2021-11-14 4 Stenhouse Mark RXDX Stock Option (Right to Buy) A - Award D 36.32 70,371 70,371
2021-11-16 2021-11-14 4 McKenna Mark C. RXDX Stock Option (Right to Buy) A - Award D 36.32 290,000 290,000
2021-11-16 2021-11-14 4 Luo Allison RXDX Stock Option (Right to Buy) A - Award D 36.32 113,677 113,677
2021-09-15 2021-09-08 4 Luo Allison By Spouse RXDX Stock Option (Right to Buy) A - Award I 25.45 4,500 4,500
2021-06-25 3 Cedars Sinai Intellectual Property Co RXDX Common Stock I 5,008,508
2021-05-17 2021-05-14 4 Hassan Fred RXDX Stock Option (Right to Buy) A - Award D 16.82 40,000 40,000
2021-04-16 2021-04-14 4 Laur James RXDX Stock Option (Right to Buy) A - Award D 22.48 40,000 40,000
2021-04-16 2021-04-14 4 Hendrix Martin RXDX Stock Option (Right to Buy) A - Award D 22.48 40,000 40,000
2021-03-18 2021-03-16 4 Cormorant Asset Management, LLC See Footnotes RXDX Series D-2 Convertible Preferred Stock C - Conversion I -1,084,696 0
2021-03-18 2021-03-16 4 Cormorant Asset Management, LLC See Footnotes RXDX Series D-1 Convertible Preferred Stock C - Conversion I -763,327 0
2021-03-18 2021-03-16 4 Cormorant Asset Management, LLC See Footnotes RXDX Common Stock P - Purchase I 19.0000 375,000 7,125 2,223,022
2021-03-18 2021-03-16 4 Cormorant Asset Management, LLC See Footnotes RXDX Common Stock C - Conversion I 1,848,022 1,848,022
2021-03-17 2021-03-16 4 Point72 Biotech Private Investments, LLC RXDX Series D-2 Preferred Stock C - Conversion I -10,846,968 0
2021-03-17 2021-03-16 4 Point72 Biotech Private Investments, LLC RXDX Series D-1 Preferred Stock C - Conversion I -7,633,277 0
2021-03-17 2021-03-16 4 Point72 Biotech Private Investments, LLC RXDX Common Stock P - Purchase I 19.0000 800,000 15,200 2,648,024
2021-03-17 2021-03-16 4 Point72 Biotech Private Investments, LLC RXDX Common Stock C - Conversion I 1,084,697 1,848,024
2021-03-17 2021-03-16 4 Point72 Biotech Private Investments, LLC RXDX Common Stock C - Conversion I 763,327 763,327
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Series D-2 Preferred Stock C - Conversion D -3,615,656 0
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Series D-1 Preferred Stock C - Conversion D -2,544,425 0
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Series C Preferred Stock C - Conversion D -25,000,000 0
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Series B Preferred Stock C - Conversion D -12,000,000 0
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Series A Preferred Stock C - Conversion D -1,000,000 0
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Common Stock C - Conversion D 361,566 5,008,508
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Common Stock C - Conversion D 254,442 4,646,942
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Common Stock C - Conversion D 2,500,000 4,392,500
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Common Stock C - Conversion D 1,200,000 1,892,500
2021-03-16 2021-03-16 4 CEDARS SINAI MEDICAL CENTER RXDX Common Stock C - Conversion D 100,000 692,500
2021-03-16 2021-03-16 4 Yamada Tadataka RXDX Series B Preferred Stock C - Conversion D -133,334 0
2021-03-16 2021-03-16 4 Yamada Tadataka RXDX Common Stock C - Conversion D 13,333 13,333
2021-03-16 2021-03-16 4 Stenhouse Mark RXDX Common Stock P - Purchase D 19.0000 14,000 266 14,000
2021-03-16 2021-03-16 4 PAPA JOSEPH C RXDX Common Stock P - Purchase D 19.0000 15,000 285 15,000
2021-03-16 2021-03-16 4 Adams Helen C. RXDX Common Stock P - Purchase D 19.0000 500 10 500
2021-03-16 2021-03-16 4 PERCEPTIVE ADVISORS LLC RXDX Series D-2 Convertible Preferred Stock C - Conversion I -14,462,623 0
2021-03-16 2021-03-16 4 PERCEPTIVE ADVISORS LLC RXDX Series D-1 Convertible Preferred Stock C - Conversion I -10,177,703 0
2021-03-16 2021-03-16 4 PERCEPTIVE ADVISORS LLC RXDX Common Stock P - Purchase I 19.0000 850,000 16,150 3,314,032
2021-03-16 2021-03-16 4 PERCEPTIVE ADVISORS LLC RXDX Common Stock C - Conversion I 1,446,262 2,464,032
2021-03-16 2021-03-16 4 PERCEPTIVE ADVISORS LLC RXDX Common Stock C - Conversion I 1,017,770 1,017,770
2021-03-16 2021-03-16 4 RTW INVESTMENTS, LP By RTW RXDX Series D-2 Preferred Stock C - Conversion I -14,462,623 0
2021-03-16 2021-03-16 4 RTW INVESTMENTS, LP By RTW RXDX Series D-1 Preferred Stock C - Conversion I -10,177,703 0
2021-03-16 2021-03-16 4 RTW INVESTMENTS, LP By RTW RXDX Common Stock C - Conversion I 1,446,262 3,264,031
2021-03-16 2021-03-16 4 RTW INVESTMENTS, LP By RTW RXDX Common Stock C - Conversion I 1,017,769 1,817,769
2021-03-16 2021-03-16 4 RTW INVESTMENTS, LP By RTW RXDX Common Stock P - Purchase I 19.0000 800,000 15,200 800,000
2021-03-11 2021-03-11 4 Szela Mary T RXDX Stock Option (Right to Buy) A - Award D 19.00 40,000 40,000
2021-03-11 3 CEDARS SINAI MEDICAL CENTER RXDX Common Stock D 592,500
2021-03-11 3 Luo Allison By spouse RXDX Common Stock I 67,708
2021-03-11 3 Luo Allison RXDX Common Stock D 50,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista